Zumin Xu

583 total citations
24 papers, 427 citations indexed

About

Zumin Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zumin Xu has authored 24 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Zumin Xu's work include MicroRNA in disease regulation (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zumin Xu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Zumin Xu collaborates with scholars based in China and United States. Zumin Xu's co-authors include Yufang Zuo, Zhonghua Yu, Guoquan Gao, Zhonghan Yang, Weibin Cai, Xia Yang, Shuhuan Fang, Mei Xiang, Zhiyu Dai and Ti Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zumin Xu

23 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zumin Xu China 13 294 141 109 47 44 24 427
Qiaoru Guo China 8 241 0.8× 145 1.0× 131 1.2× 58 1.2× 54 1.2× 15 437
Jianbing Hou China 13 408 1.4× 148 1.0× 154 1.4× 51 1.1× 60 1.4× 24 629
Chien-Yu Chen United States 5 314 1.1× 157 1.1× 86 0.8× 40 0.9× 39 0.9× 7 475
Nick A. Kuburich United States 7 260 0.9× 117 0.8× 134 1.2× 55 1.2× 51 1.2× 14 443
Rossella Loria Italy 10 271 0.9× 161 1.1× 85 0.8× 56 1.2× 47 1.1× 14 449
Lalita Yadav India 5 213 0.7× 153 1.1× 134 1.2× 35 0.7× 30 0.7× 13 407
Hala Elnakat Thomas United States 9 312 1.1× 110 0.8× 68 0.6× 48 1.0× 27 0.6× 9 460
Siming Xie China 11 317 1.1× 118 0.8× 139 1.3× 55 1.2× 36 0.8× 24 519
Che-Chia Hsu United States 6 387 1.3× 145 1.0× 91 0.8× 50 1.1× 70 1.6× 10 504

Countries citing papers authored by Zumin Xu

Since Specialization
Citations

This map shows the geographic impact of Zumin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zumin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zumin Xu more than expected).

Fields of papers citing papers by Zumin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zumin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zumin Xu. The network helps show where Zumin Xu may publish in the future.

Co-authorship network of co-authors of Zumin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zumin Xu. A scholar is included among the top collaborators of Zumin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zumin Xu. Zumin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Yang, Donghong, et al.. (2022). Metformin Sensitizes Cisplatin-induced Apoptosis Through RegulatingNucleotide Excision Repair Pathway In Cisplatin-resistant Human LungCancer Cells. Letters in Drug Design & Discovery. 19(12). 1086–1095. 4 indexed citations
4.
Xu, Zumin, et al.. (2021). Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer. Frontiers in Genetics. 11. 616998–616998. 18 indexed citations
5.
Li, Jingjing, Mei Xiang, Jun Yang, et al.. (2018). Niclosamide sensitizes nasopharyngeal carcinoma to radiation by downregulating Ku70/80 expression. Journal of Cancer. 9(4). 736–744. 8 indexed citations
6.
Yang, Qingmei, Yuan Liu, Yan Peng, et al.. (2018). MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7. Technology in Cancer Research & Treatment. 17. 1077077641–1077077641. 31 indexed citations
7.
8.
Fang, Shuhuan, Honghai Hong, Lei Li, et al.. (2017). Plasminogen kringle 5 suppresses gastric cancer via regulating HIF-1α and GRP78. Cell Death and Disease. 8(10). e3144–e3144. 15 indexed citations
9.
Zuo, Yufang, Dongyan Yang, Mei Xiang, et al.. (2017). Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. Molecular Medicine Reports. 17(3). 3497–3502. 20 indexed citations
10.
Zhang, Ting, Ping Yin, Zichen Zhang, et al.. (2017). Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial–mesenchymal transition and metastasis. Cell Death and Disease. 8(6). e2838–e2838. 20 indexed citations
11.
12.
Xu, Zumin, Yufang Zuo, Jin Wang, et al.. (2015). Overexpression of the regulator of G-protein signaling 5 reduces the survival rate and enhances the radiation response of human lung cancer cells. Oncology Reports. 33(6). 2899–2907. 15 indexed citations
13.
Hong, Honghai, Ti Zhou, Shuhuan Fang, et al.. (2014). Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin. Breast Cancer Research and Treatment. 148(1). 61–72. 46 indexed citations
14.
Yu, Ying, Zumin Xu, Dongyan Yang, et al.. (2014). Antisense oligonucleotides targeting human telomerase mRNA increases the radiosensitivity of nasopharyngeal carcinoma cells. Molecular Medicine Reports. 11(4). 2825–2830. 12 indexed citations
15.
Chen, Xinggui, Ying Yu, Zhennan Wang, et al.. (2014). Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway. Oncology Reports. 32(6). 2596–2604. 28 indexed citations
16.
Zuo, Yufang, et al.. (2014). A new version of targeted minicircle producer system for EBV-positive human nasopharyngeal carcinoma. Oncology Reports. 32(6). 2564–2570. 4 indexed citations
17.
Peng, Fang, Zumin Xu, Jin Wang, et al.. (2012). Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models. PLoS ONE. 7(4). e34646–e34646. 56 indexed citations
18.
Bao, Yong, Xiao Hu, Yan Wang, et al.. (2012). A prospective phase I / II study of recombinant endostatin (Endostar) combined with concurrent radio-chemotherapy in patients with unresectable stage III non-small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 21(6). 500–503. 1 indexed citations
19.
20.
Yang, Xia, Weibin Cai, Zumin Xu, et al.. (2009). High efficacy and minimal peptide required for the anti‐angiogenic and anti‐hepatocarcinoma activities of plasminogen K5. Journal of Cellular and Molecular Medicine. 14(10). 2519–2530. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiaoru Guo Breakdown of academic impact, for papers by Jianbing Hou Breakdown of academic impact, for papers by Chien-Yu Chen Breakdown of academic impact, for papers by Nick A. Kuburich Breakdown of academic impact, for papers by Rossella Loria Breakdown of academic impact, for papers by Lalita Yadav Breakdown of academic impact, for papers by Hala Elnakat Thomas Breakdown of academic impact, for papers by Siming Xie Breakdown of academic impact, for papers by Che-Chia Hsu
Rankless by CCL
2026